SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sepracor-Looks very promising

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: rkrw who started this subject10/4/2000 12:35:52 PM
From: MarkR37  Read Replies (2) of 10280
 
Thanks to JimPd on the SEPR club thread for this. What are the chances Nora will be one of the 10?

UBS Warburg Global Life Sciences conference:
700 million cash on hand will take to profitablilty.
Laid out profit goals but did not predict
when would be achieved.
Burn rate in 2000 200-250 million
Will launch 10 drugs over 4 years using
own sales force
Will expand Xopenex franchise.Now have 12%
of market in terms of unti volume.
Japanese approval of Allegra(already done?)
EOY European filing of SEPR version of Zyrtec
EOY DCL approval
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext